FDA Drug Application (018841) for DAYPRO by GD SEARLE

Back to FDA Applications sponsored by GD SEARLE

Application Number018841
Product Number004
FormTABLET;ORAL
Dosage600MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDAYPRO
Active IngredientOXAPROZIN

Active IngredientCount
List of drugs with Active Ingredient OXAPROZIN2


Back to FDA Applications sponsored by GD SEARLE